logo

For the Inventor, By the Inventor

Rueil Malmaison, France

Michele Launay

USPTO Granted Patents = 14

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 79(Granted Patents)


Company Filing History:

goldMedal7 out of 3,684 
 
Bristol-myers Squibb Compnay
 patents
silverMedal5 out of 22 
 
Laboratoires Upsa
 patents
bronzeMedal5 out of 5 
 
Cerep Sa
 patents
4. 1 out of 1 
 
Centre D'activite Et De Recherches Pharmaceutique Industrielle
 patent
5. 1 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1989-2008

Loading Chart...
14 patents (USPTO):Explore Patents
1. 7375237 - Pyrrolizine compounds useful as anti-inflammatory agents (2008-05-20),
2. 7199125 - Spiro-cyclic compounds useful as anti-inflammatory agents (2007-04-03),
3. 7186727 - Pyridyl-substituted spiro-hydantoin compounds and use thereof (2007-03-06),
4. 7078420 - Spiro-hydantoin compounds useful as anti-inflammatory agents (2006-07-18),
5. 6977267 - Spiro-hydantoin compounds useful as anti-inflammatory agents (2005-12-20),
6. 6974815 - Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents (2005-12-13),
7. 6710064 - Hydantoin compounds useful as anti-inflammatory agents (2004-03-23),
8. 6673825 - Urazole compounds useful as anti-inflammatory agents (2004-01-06),
9. 6004994 - Heterocyclic diarylmethylene derivatives, methods of preparing them and (1999-12-21),
10. 5686460 - Carbocyclic diarylmethylene derivatives, processes for their preparation (1997-11-11),
11. 5663181 - Naphthyridine derivatives, their methods of preparation and (1997-09-02),
12. 5364860 - Naphthyridine compounds which inhibit tyrosine kinase and their (1994-11-15),
13. 5192781 - Thiazole derivatives which are angiotensin II receptor antagonists, (1993-03-09),
14. 4886805 - Novel aminoalkylthio derivatives of triazolopyridine or (1989-12-12),

Title: Michele Launay: Innovator in Anti-Inflammatory Compounds

Introduction

Michele Launay is a prominent inventor based in Rueil Malmaison, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-inflammatory agents. With a total of 14 patents to her name, Launay's work has had a substantial impact on the treatment of inflammatory and immune diseases.

Latest Patents

Among her latest patents are innovative pyrrolizine compounds that are effective in treating inflammatory or immune diseases. These compounds are characterized by a specific formula, where A represents a four- to seven-membered saturated ring, K can be either O or S, and R, R, Rn, and M are defined in the specification. Additionally, she has developed spiro-cyclic compounds that also serve as anti-inflammatory agents. These compounds are designed to treat similar conditions and include a formula where K and L are independently O or S, and Q is a specific carbon structure.

Career Highlights

Michele Launay has worked with notable companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and Laboratoires Upsa. Her experience in these organizations has allowed her to refine her expertise in drug development and innovation.

Collaborations

Throughout her career, Launay has collaborated with esteemed colleagues, including Dominique Potin and Eric Nicolai. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Michele Launay is a distinguished inventor whose work in anti-inflammatory compounds has made a significant impact in the medical field. Her innovative patents and collaborations highlight her dedication to improving treatments for inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…